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  Abstract 
    Objective.   Little is known about the relevance of lesion in neural circuits reported to be associated with major depressive 
disorder. We investigated the association between lesion stroke size in the limbic-cortical-striatal-pallidal-thalamic (LCSPT) 
circuit and incidence of major depressive episode (MDE).   Methods.   We enrolled 68 patients with ﬁ  rst-ever ischemic stroke 
and no history of major depressive disorder. Neurological and psychiatric examinations were performed at three time-points. 
We diagnosed major depressive episode, following DSM-IV criteria. Lesion location and volume were determined with mag-
netic resonance imaging, using a semi-automated method based on the Brodmann Cytoarchitectonic Atlas.   Results.   Twenty-
one patients (31%) experienced major depressive episode. Larger lesions in the left cortical regions of the LCSPT circuit 
(3,760 vs. 660 mm  3  ;   P         0.004) were associated with higher incidence of MDE. Secondary analyses revealed that major 
depressive episode was associated with larger lesions in areas of the medial prefrontal cortex including the ventral (BA24) 
and dorsal anterior cingulate cortex (BA32) and subgenual cortex (BA25); and also the subiculum (BA28/36) and amygdala 
(BA34).   Conclusions   Our ﬁ  ndings indicate that depression due to stroke is aetiologically related to the disruption of the left 
LCSPT circuit and support the relevance of the medial prefrontal cortex dysfunction in the pathophysiology of depression.   
    Key words:     Cingulate gyrus    ,    depression disorder    ,    magnetic resonance imaging    ,    prefrontal cortex    ,    stroke     
    Introduction 
  The reported prevalence of major depression within 
3 months after stroke ranges from 22 to 31% 
(Robinson et al. 1984b; Astrom et al. 1993; Terroni 
et al. 2003; Spalletta et al. 2005). Efforts to identify 
biological and psychosocial mechanisms have provided 
evidence that the aetiology of post-stroke depression 
is multifactorial (Robinson et al. 1984a; Astrom et al. 
1993; Andersen et al. 1995; Vataja et al. 2001). How-
ever, research focusing on stroke location has been a 
fruitful strategy in understanding the pathophysiology 
of post-stroke depression (Robinson et al. 1984a; 
Mayberg et al. 1988; Astrom et al. 1993; Vataja et al. 
2001; Vataja et al. 2004). From a clinical perspective, 
knowing which patients are at increased risk of devel-
oping post-stroke depression may ameliorate the 
prevention, detection, and early treatment of depres-
sion, consequently reducing its the negative impact 
on the recovery of stroke patients (Ramasubbu and 
Kennedy 1994). 
  Although there is no consensus about the relationship 
between lesion location and post-stroke depression 
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depression, we also investigated the relationship 
between lesions in speciﬁ  c brain areas incorporated 
in those circuits and incidence of major depressive 
episodes.     
  Methods   
  Patients 
  We screened 326 male and female patients, 18 years 
of age or older, consecutively admitted to the 
Neurology Unit of a University Hospital with a diag-
nosis of ischemic stroke between August of 2002 and 
May of 2008. The diagnosis of stroke was made by 
a neurologist in accordance with the World Health 
Organization criteria (WHO 1989) and conﬁ  rmed 
by MRI. A psychiatrist administered the modules for 
mood episodes, psychotic symptoms and substance 
use disorders of the Structured Clinical Interview 
(SCID) for Diagnostic and Statistical Manual of 
Mental Disorders fourth edition (DSM-IV) to 
investigate past and current psychiatric disorders 
(American Psychiatric Association 1994; First 1995). 
This interview was performed with the patient and 
a family member/caregiver present when possible. 
Patients with previous history of stroke or other cen-
tral nervous system diseases (i.e. amyotrophic lateral 
sclerosis, subarachnoid haemorrhage, Binswanger  '  s 
disease, brain tumours, or multiple sclerosis) were 
excluded from the study, as were those with infraten-
torial stroke, a severe clinical condition that impeded 
the interview, Cushing  '  s syndrome, alcohol or drug 
dependence in the last 12 months, previous history 
of major depressive episode or bipolar disorder, cur-
rent major depressive episode or bipolar disorder 
with pre-stroke onset, psychotic disorder, dementia, 
or aphasia that impeded the interview. On the basis 
of these criteria, we excluded 234 patients (Figure 1): 
history stroke, infratentorial stroke, greater than 
2-week interval between stroke occurrence and 
screening interview, or haemorrhagic transformation 
of stroke (  N         89); drug/alcohol dependence, psy-
choses, delirium, history of major depressive episode, 
current major depressive episode with pre-stroke 
onset, dysthymia, or bipolar disorder (  N         54); 
aphasia that impeded the interview (  N         37); neu-
rological diseases or severe clinical condition that 
impeded the interview (  N         22); and other reasons 
(  N         32). Of the remaining 92 patients, ﬁ  ve declined 
to participate in the study. Of those 87 patients, 
19 were later excluded due to problems during the 
MRI acquisition: image was inappropriate for use in 
the present study (  N         15); claustrophobia (  N         3); 
and haemorrhagic transformation of stroke (  N         1). 
Therefore, we enrolled a ﬁ  nal sample of 68 patients. 
Nine patients dropped out after the ﬁ  rst time-point 
(Singh et al. 1998; Carson et al. 2000; Bhogal et al. 
2004; Hackett and Anderson 2005), some studies 
using computed tomography, magnetic resonance 
imaging (MRI) (Robinson et al. 1984a; Astrom et al. 
1993; Vataja et al. 2001, 2004) and PET imaging of 
cortical S2 serotonin receptors (Mayberg et al. 1988) 
have suggested that post-stroke depression is associ-
ated with the proximity of the lesion to the frontal 
lobe and with left hemisphere stroke. In addition, 
studies in major depressive disorder with PET 
(Baxter et al. 1989; Drevets et al. 1992), and with 
catecholamine depletion (Hasler et al. 2008), have 
found abnormal prefrontal function, more commonly 
in the left than in the right hemisphere. 
  MRI studies (Vataja et al. 2001, 2004) have reported 
a high prevalence of post-stroke depression in lesions 
affecting some structures of the prefronto-subcortical 
circuit, particularly in the left hemisphere, a circuit 
that has been reported to be involved in various neu-
ropsychiatry syndromes, including depression. Recent 
studies have highlighted the speciﬁ   c relevance of 
the limbic-cortical-striatal-pallidal-thalamic (LCSPT) 
circuit in the pathophysiology of major depressive dis-
order (Drevets et al. 2008; Hasler et al. 2008). Based 
on evidence from animal studies, Drevets et al. (2008) 
proposed that in addition to the LCPSPT circuit, two 
other circuits are essential for emotional regulation. 
The ﬁ  rst, the orbital prefrontal network, is involved 
in a system of reward, aversion, and relative value. 
The second, the medial prefrontal network, has con-
nections with limbic and visceral control structures 
that are involved in introspective functions such as 
mood and emotion, and visceral reactions to emo-
tional stimuli such as autonomic regulation and neu-
roendocrine responses. The prefrontal cortex, which 
includes areas belonging to all these circuits, has been 
implicated in response to treatment for major depres-
sive disorder (Mayberg et al. 1997; Brody et al. 1999; 
Pizzagalli et al. 2001). 
  To our knowledge, there have been no studies 
investigating the relationship between stroke lesions 
in LCSPT circuit and the development of post-stroke 
depression. Therefore, the primary aim of the pres-
ent study was to investigate the association between 
lesion volume in the left LCSPT circuit and the inci-
dence of major depressive episode in the ﬁ  rst four 
months after stroke. We focused on the left hemi-
sphere as the left lateralization of stroke has been 
repeatedly associated with post-stroke depression 
(Robinson et al. 1984a; Astrom et al. 1993; Vataja 
et al. 2001, 2004; Bhogal et al. 2004). As secondary 
hypothesis, we investigated the association between 
the incidence of major depressive episode and lesions 
involving cortical regions of the orbital and medial 
prefrontal networks. When cortical circuits were 
found to be statistically associated with post-stroke Stroke  lesion  and  major  depression        541
  MRI methods 
  The MRIs were acquired in general within two 
weeks after stroke (9.34       6.87; range 1  –  43 days). 
All images were acquired using a 1.5-Tesla system 
(GE-Horizon LX). The imaging protocol included 
axial spoiled gradient recalled acquisition in steady 
state (SPGR, TR       27 ms; ﬂ  ip angle       45  °  ; voxel 
size       0.94       0.94       1.5 mm), axial ﬂ  uid attenu-
ated inversion recovery (FLAIR, TR       133 ms; 
TE       8400 ms; TI       2100 ms; voxel size       0.94 
      0.94       5 mm), axial diffusion-weighted image 
(TR       8000 ms;   b   value       1000 s/mm  2  ; voxel 
size       1.8       1.8       5 mm), T2-weighted fast spin 
echo (TR       4500 ms; TE       100  –  120 ms; voxel 
size       0.94       0.94       5 mm). All images were 
acquired in the bicommissural plane. 
  Lesion location and volume quantiﬁ  cation were 
determined using a semi-automated method. Ini-
tially, SPGR and axial FLAIR acquisitions were both 
normalized to the Montreal Neurological Institute 
template (Evans et al. 1993) using linear transforma-
tion with 12 degrees of freedom and 15 nonlinear 
interactions implemented in Statistical Parametric 
Mapping (SPM5,Wellcome Trust for Neuroimaging, 
London, http://www.ﬁ  l.ion.ucl.ac.uk/spm/) (Friston 
et al. 1996), and based on coordinates referenced in 
the Talairach and Tournoux Atlas (Talairach and 
Tornoux 1988). During this process, all images 
were sampled to 2.3       2.3       2.6 mm. Lesion delin-
eation was performed by a trained psychiatrist 
(LT) using a mouse device to trace the ischemic 
lesion and analyzing all slices of each FLAIR image 
using MRIcro Software (http://www.sph.sc.edu/
comd/rorden/mricro.html) (Rorden and Brett 2000). 
All lesions delineations of each patient were reviewed 
by a neuroradiologist (EAJ), blinded for clinical data 
and psychiatric diagnoses. 
  RF had elaborated the main hypothesis of the 
study related to the lesions in the LCSPT and post-
stroke depression but did not disclose it to the raters 
of MRI lesions (LT, EA) while lesion delineation was 
taking place, in order to preserve the blinding. Both 
raters delineating MRI lesions (LT, EAJ) were only 
aware they would study size and location of the 
lesions using the Brodmann Map in relation to post 
stroke depression. Both raters (LT, EA) were also 
blind to the clinical outcome status (post stroke 
depression episodes) of the patients while delineating 
lesions on MRIs. After ﬁ  nishing the lesion delinea-
tion process, RF (who had not participated in lesion 
delineation) revealed the speciﬁ  c hypothesis to be 
tested. Diffusion-weighted images were also ana-
lyzed in order to distinguish between other possible 
differential diagnoses. The regions of interest were 
then analyzed automatically using the Brodmann 
examination and four patients dropped out after the 
second time-point examination. The institutional 
review board of the Clinics Hospital approved the 
study protocol and, written informed consent was 
obtained from all participating patients.     
  Clinical assessments 
  The enrolled patients were evaluated at three dif-
ferent time-points: between post-stroke days 5 and 
25 (mean       SD; 12.0       4.5; range, 5  –  23 days); 
between post-stroke days 30 and 59 (37.0       6.0; 
30  –  57 days); and, between post-stroke days 80 and 
110 (91.6       5.4; 83  –  108 days). In all three evalua-
tions, the diagnosis of major depressive episode was 
made by an experienced psychiatrist (LT), blinded 
for imaging data, using the SCID for DSM-IV, 
Axis I disorders (American Psychiatric Association 
1994; First 1995). In the ﬁ   rst evaluation in the 
Neurology Unit, as we described in a previous work 
(Terroni et al. 2009), the diagnosis of major depres-
sive episode was made considering a period of 
1 week, as have been done in others studies (Robinson 
et al. 1984a; Astrom et al. 1993; Caeiro et al. 2006). 
The 31-item Hamilton Rating Scale for Depression 
(HAM  –  D-31) (Williams 1988; Jamerson et al. 2003) 
was used at every visit to assess the severity of depres-
sive symptoms. At all three time-points, a neurologist 
(GT), certiﬁ  ed by the National Institutes of Health 
to administer the National Institutes of Health 
Stroke Scale (NIHSS) (Brott et al. 1989), blinded 
for imaging data and psychiatric diagnoses, evaluated 
the stroke severity using the NIHSS and the impair-
ment of activities of daily living using the Barthel 
Index (Herndon 1997). Cognitive performance was 
assessed at the ﬁ  rst and third time-points with the 
Mini-Mental State Examination (MMSE) (Folstein 
et al. 1975) administered by a neuropsychologist (MS) 
blinded for imaging data and psychiatric diagnoses.     
Inclusion criteria not met (n=234) 
No agreement to participate (n=5) 
Enrolled patients followed 
for 4 months (n = 87) 
Problems in acquisition of MRI 
scans (n=19) 
Clinical diagnosis of stroke 
confirmed by MRI (n = 326) 
Final sample 
First evaluation: 5–25 days after stroke (n = 68)  
Second evaluation: 30–57 days after stroke (n = 59) 
Third evaluation: 80–110 days after stroke (n = 55) 
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LCSPT with the incidence of post-stroke major 
depressive episode. To test our secondary hypotheses 
we investigated whether major depressive episode 
incidence was associated with the orbital prefrontal 
network and medial prefrontal network in the left 
hemisphere and with the three target circuits in the 
right hemisphere. When we found a signiﬁ  cant asso-
ciation for a given circuit, we performed comple-
mentary analyses to investigate whether a lesion 
volume in a speciﬁ  c BA in that circuit was associated 
with the incidence of major depressive episode. Two 
patients with bilateral stroke were excluded from the 
analyses. Lesion volume is expressed as mean and 
standard deviation of voxels in mm  3   (FLAIR voxel 
size 2.3       2.3       2.6 mm). 
  Statistical analyses were performed using the 
Statistical Package for the Social Sciences, version 
14 (Chicago: Il, SPSS inc., 2005). The Chi  -  square 
test or Fisher  '  s exact test were used for categorical 
data, and the   t  -test was used for continuous variables, 
and the Mann  –  Whitney   U  -test was used when 
data did not have normal distribution according to 
the Kolmogorov  –  Smirnov test. Results are presented 
as frequencies, values of the rank mean and rank 
sum in the Mann  –  Whitney   U  -test, and also mean       
standard deviation. All statistical tests were based on 
two-tailed signiﬁ  cance. 
  To account for multiple comparisons and to 
minimize type I errors we followed Hochberg  ’  s 
recommendations (Hochberg 1988). Thus, we 
tested our main hypothesis related to left sided 
LCSPT circuit at   α         0.05, our hypothesis related 
to left sided orbital prefrontal network at   α         0.025 
and the hypothesis related to left sided medial pre-
frontal network at   α         0.0166. For the right sided 
circuits we tested at the following   P   values: right 
LCSPT circuit at   α         0.0125, right orbital pre-
frontal network at   α         0.01 and right medial pre-
frontal network at   α         0.0083. The order of these 
comparisons was pre-determined by our hypo-
theses. For circuits where overall   P   values were sta-
tistically  signiﬁ   cant after multiplicity adjustments 
we investigated associations with individual BAs at 
  P         0.05 level.       
  Results   
  Demographic and clinical data 
  Twenty-one patients (31%) were diagnosed with a 
new-onset major depressive episode, including seven 
at the time of the ﬁ  rst evaluation, ﬁ  ve at the second 
and, nine at the third evaluation. The depressed 
patients were comparable to those without major 
depressive episode in terms of sociodemographic, 
clinical, neurological, lesions in white matter, and 
Cytoarchitectonic Atlas registered to the same space 
(Van Essen and Drury 1997; Van Essen et al. 1998), 
in order to count the number of voxels within each 
Brodmann area (BA). The total lesion volume was 
obtained by multiplying the number of voxels by 
voxel size in normalized images. Lesions in the white 
matter substance were classiﬁ   ed with the Fazekas 
scale, which provides an assessment of severity of the 
white-matter hyperintensities in the periventricular 
area (PWMH) and in the deep white-matter (DWMH) 
(Fazekas et al. 1987; Iosifescu et al. 2006).This 
process was made by a neuroradiologist (EA) blinded 
to the clinical status of the patients.     
  Neural circuit: deﬁ  nitions 
  Our main hypothesis was that post-stroke major 
depressive episode was associated with lesion volume 
in the LCSPT circuit (Drevets et al. 2008) in the left 
hemisphere. 
  The LCSPT circuit is composed of connections 
between the orbital prefrontal cortex and medial 
prefrontal cortex (Ongur et al. 2003). We selected 
the BAs included in each of these circuits according 
to their neuroanatomical deﬁ  nitions  (Brodmann 
1909; Ongur and Price 2000; Ongur et al. 2003; 
Drevets et al. 2008). The BAs included in the LCSPT 
circuit are: BA11, BA12, BA13 and BA47 (orbital 
prefrontal cortex); BA9, BA10, BA11, BA13, BA14, 
BA24, BA25, BA32 and BA47 (medial prefrontal 
cortex); BA34 (amygdala); and BA28/BA36 (corre-
sponding to the subiculum). Subcortical structures 
of the LCSPT circuit were not included because 
the Brodmann map comprises primarily cortical 
structures. 
  As secondary hypotheses, we investigated the asso-
ciation between post-stroke major depressive episode 
and two networks (Drevets et al. 2008). The orbital 
prefrontal network includes the orbital prefrontal 
cortex together with the following areas: BA20 (infe-
rior temporal cortex); BA13/BA14 (insula); BA44/
BA45 (frontal operculum); BA27/BA34 (olfactory 
cortex); and BA43 (taste cortex). The second, the 
medial prefrontal network including the medial pre-
frontal cortex, together with the following areas: 
BA23/BA31 (mid/posterior cingulate cortex); BA22/
BA38 (anterior superior temporal gyrus/sulcus); 
BA28/BA34 (entorhinal cortex); and BA35/BA36 
(posterior parahippocampal cortex).     
  Statistical analysis 
  The lesion volume for a given circuit was obtained 
by determining the voxel-based lesion morphometry 
in that circuit. To test our main hypothesis we inves-
tigated the association of lesion volume in the left Stroke  lesion  and  major  depression        543
cognitive aspects, with the exception of an increased 
rate of Diabetes Mellitus among depressed patients 
(Table I). Thirty-nine patients (57.4%) had suffered 
a left hemisphere stroke, 27 (39.7%) had suffered a 
right hemisphere stroke and 2 (2.9%) had suffered 
a bilateral stroke. 
  There were no signiﬁ  cant differences between the 
patients included in the ﬁ  nal study (  N         68) and 
those who had been excluded because of problems 
in the MRI acquisitions (  N         19) in terms of socio-
demographic, neurological, and cognitive measures, 
except for the fact that NIHSS scores were lower in 
the studied patients at the ﬁ  rst time-point, but not 
at the second and third time-points.     
  Analysis of lesion location and volume 
in neural circuit 
  Patients with ﬁ   rst major depressive episode after 
stroke had larger lesion volume in the left LCSPT 
circuit than non-depressed patients (respectively 
3,760 vs. 660 mm  3  ;   P         0.004; Table II). The inci-
dence of major depressive episode was also associ-
ated with lesion volume in the left orbital prefrontal 
network (  P         0.037), our secondary hypothesis, 
but this comparison did not reach statistical signi-
ﬁ   cance after Hochberg  '  s multiplicity adjustments 
(  P         0.025). Complementary analyses revealed that 
major depressive episode incidence was associated 
with speciﬁ  c areas of the left LCSPT circuit (Table III) 
including the ventral anterior cingulate cortex (BA24), 
subgenual cortex (BA25), subiculum (BA28/BA36), 
amygdala (BA34), and dorsal anterior cingulate 
cortex (BA32). 
  Due to the increased rate of diabetes mellitus 
among depressed patients and its potential con-
founding effect, we investigate the association 
between diabetes and stroke location. The presence 
of diabetes mellitus was not associated with lesions 
in the LCSPT circuit (  P         1.00). The distribution 
of handedness among patients with left hemisphere 
lesions was similar between those with and without 
major depressive episode. Among patients with left 
hemisphere lesions all the 12 (100%) patients with 
major depressive episode were right-handed and 
regarding the non-depressed patients 25 (92.6%) 
were right-handed and 2 (7.4%) were left-handed 
(  P         1.00)       
  Discussion 
  In this 4-month prospective study, we found an asso-
ciation between the post-stroke incidence of major 
depressive episode and lesion volume in the left 
LCSPT circuit. Although this neural circuit was pre-
viously described to be affected in major depressive 
    Table I. Demographic and clinical characteristics of patients with 
and without major depressive episode after stroke.   
Major depressive episode
Yes
N (%)
No
N (%) P value
Patients 21 (31) 47 (69)
Sex
Female 10 (48) 22 (47)
Male 11 (52) 25 (53) 0.951
Married
yes 15 (71) 29 (62)
no 6 (29) 18 (38) 0.606
Level of educational
 8 years of schooling 16 (76) 32 (68)
 9 years of schooling 5 (24) 15 (32) 0.435
Employed
yes 11 (52) 32 (68)
no 10 (48) 15 (32) 0.215
Left hemisphere lesion
yes 13 (62) 28 (59.6)
no 8 (38) 19 (40.4) 0.856
Right hemisphere lesion
yes 9 (42.9) 20 (42.6)
no 12 (57.1) 27 (57.5) 0.981
Handenessb
Right-handed 21 (100) 44 (93.6)
Left-handed 0 (0) 3 (6.4) 0.547
HTNc
Yes 12 (57.1) 22 (50)
No 9 (42.9) 22 (50) 0.590
DMb,c
Yes 6 (28,6) 3 (6.8)
No 15 (71.4) 41 (93.2) 0.048
CHDb,c
Yes 1 (5) 1 (2.2)
No 19 (95) 44 (97.8) 0.524
Dysphasiab,d
Yes 1 (4.8) 8 (19)
No 20 (95.2) 34 (81) 0.251
White-matter hyperintensity
 scoree
PWMH 0.182
PWMH   0 2 (9.5) 2 (4.3)
PWMH   1 13 (61.9) 39 (83)
PWMH   2 5 (23.8) 6 (12.8)
PWMH   3 1 (4.8) 0 (0)
DWMH 0.486
DWMH   0 6 (28.6) 12 (25.5)
DWMH   1 10 (47.6) 23 (48.9)
DWMH   2 3 (14.3) 11 (23.4)
DWMH   3 2 (9.5) 1 (2.1)
Mean (SD) Mean (SD)
Age, years 53.8 (15.8) 49.8 (12.8) 0.280
NIHSSa
First time-point 3.7 (3.0) 2.7 (2.7) 0.134
Second time-point 2.8 (2.4) 2.4 (2.7) 0.379
Third time-point 2 (1.8) 1.9 (1.9) 0.825
Barthel Indexa
First time-point 86 (24.8) 92.6 (19.1) 0.123
Second time-point 91.3 (17.4) 93.3 (17.1) 0.366
Third time-point 97.4 (5.4) 96.4 (9.5) 0.901
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Table I. (Continued)
Major depressive episode
Yes
N (%)
No
N (%) P value
MMSE
First time-point 23.5 (4.2) 23.7 (4.5) 0.933
Third time-point 24.6 (4.3) 24.4 (3.7) 0.900
HAM-D
First time-point 23 (2.9) 5.7 (3.9) <0.001
Second time-point 22.2 (6.8) 5.7 (4.6) <0.001
Third time-point 20.3 (4) 5.1 (5) <0.001
      NIHSS, National Institutes of Health Stroke Scale; MMSE, Mini-
Mental State Examination; HAM-D, Hamilton Rating Scale for 
Depression, 31-item version; HTN, hypertension; DM, diabetes 
mellitus; CHD, coronary heart disease; PWMH, periventricular 
hyperintensity; DWMH, deep white-matter hyperintensity.     
  aMann–Whitney test; bFischer’s exact test; cN   65, three cases 
with no data; dN   63, ﬁ  ve cases with no data; eFazekas Score.     
disorder, to our knowledge ours is the ﬁ  rst study to 
directly test the importance of lesions in this circuit 
in relation to post-stroke depression. The importance 
of the LCSPT circuit activity in the pathophysiology 
of major depressive disorder has recently been con-
ﬁ  rmed in a catecholamine depletion study (Hasler  et al. 2008). The metabolism of the LCSPT circuit 
was increased in remitted major depressive disorder 
subjects in response to catecholamine depletion but 
decreased or remained unchanged in healthy sub-
jects (Hasler et al. 2008). The association of post-
stroke depression with lesions in neuronal circuits 
has previously been investigated with MRI studies 
(Vataja et al. 2001, 2004). These studies reported a 
higher proportion and/or larger volume of infarcts 
in the prefrontal-subcortical circuit of post-stroke 
depressed patients compared with those non-
depressed, with differences found particularly in the 
frontal lobes, caudate, pallidum, and the genu of the 
internal capsule, with left hemisphere predominance. 
The prefrontal-subcortical circuit has been associ-
ated with behavioral syndromes such as executive 
dysfunction, irritability, disinhibition and apathy 
(Cummings 1993). 
  Our complementary analyses revealed that ﬁ  ve of 
the LCSPT areas in the left hemisphere including the 
ventral anterior cingulate cortex (BA24), subgenual 
cortex (BA25), dorsal anterior cingulate cortex 
(BA32), amygdala (BA34), and subiculum (BA28/
BA36) were individually associated with the post-
stroke incidence of major depressive episode. The 
ventral anterior cingulate cortex (BA24), subgenual 
cortex (BA25) and the dorsal anterior cingulate cor-
tex (BA32) are located in the medial prefrontal 
cortex, conﬁ  rming the relevance of the frontal lobe 
for the pathophysiology of post-stroke depression 
(Robinson et al. 1984a; Mayberg et al. 1988; Vataja 
et al. 2001, 2004). The medial prefrontal cortex 
    Table III. Complementary analysis of the association of lesion 
volume in areas of the LCSPT in the left hemisphere and incidence 
of major depressive episode.   
Major depressive episodea
P valueb Yes (n   12)c No (n   27)c
Amygdala (BA34) 87 (160) 4 (21) 0.010
24.08 (289) 18.19 (491)
Ventral anterior 
cingulate cortex 
(BA24)
690 (1,990) 0 (0) 0.032
22.25 (267) 19.00 (513)
Subgenual cortex 
(BA25)
280 (710) 4 (20) 0.038
23.00 (276) 18.67 (504)
Hippocampal 
subiculum (BA28)
39 (130) 0 (0) 0.032
22.25 (267) 19.00 (513)
Dorsal anterior 
cingulate cortex 
(BA32)
740 (2,190) 5 (24)
22.92 (275) 18.70 (505) 0.043
Hippocampal 
subiculum (BA36)
40 (120) 0 (0) 0.032
22.25 (267) 19.00 (513)
      BA, Brodmann area.     
  aMeasurement of size is in mm3 (mean   SD) in the upper line 
and value of mean rank (rank sum) in the below line.      
  bMann–Whitney test without multiple comparison adjustment.      
  cFinal sample in the group of patients.     
    Table II. Association between lesion volume in neural circuits and 
four-month incidence of major depressive episode after ischemic 
stroke.    
Major depressive episodea
P valued Yes b Noc
Left hemisphere 
  ( N   39)e
N   12 (30.8%) N   27 (69.2%)
LCSPT 3,760 (5,840) 660 (3,080) 0.004
26.21 (314.5) 17.24 (465.5)
OPFN 4,900 (10,080) 1,680 (6,230) 0.037
25.25 (303) 17.67 (477)
MPFN 4,380 (6,350) 860 (3,170) 0.065
24.58 (295) 17.96 (485)
Right hemisphere 
  ( N   27)e
N   8 (29.6%) N   19 (70.4%)
LCSPT 1,270 (1,610) 6,170 (15,650) 0.697
14.88 (119) 13.63 (259)
OPFN 3,900 (4,120) 6,300 (10,830) 0.667
15.00 (120) 13.58 (258)
MPFN 3,450 (2,720) 7,010 (15,840) 0.435
15.81 (126.5) 13.24 (251.5)
      LCSPT, limbic-cortical-striatal-pallidal-thalamic circuit; OPFN, 
orbital prefrontal network; MPFN, medial prefrontal network.      
  aMeasurement of size is in mm3 (mean   SD) in the upper line 
and value of mean rank (rank sum) in the below line.      
  bOne patient with bilateral stroke was excluded of this analysis.     
  cOne patient with bilateral stroke was excluded of this analysis.      
  dMann–Whitney test with P values of the Hochberg’s recommen-
dations: left sided LCSPT circuit at α   0.05, left sided OPFN at 
α   0.025, left sided MPFN at α   0.01667, right LCSPT circuit 
at  α   0.0125, right OPFN at α   0.01 and right MPFN at 
α   0.0083.     
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amygdala activity decreases after antidepressant 
treatment/symptom remission (Fu et al. 2004). 
Furthermore, functional coupling among the neural 
pathways of amygdala connections in the fronto-
striato-thalamic circuits has been shown to increase 
after treatment with antidepressants (Chen et al. 
2008). It has also been suggested that the subiculum 
plays a role in the pathophysiology of depression and 
hippocampal neuroplasticity (Bessa et al. 2009), albeit 
this is less extensively established than it is for the 
amygdala. Taking into account the relevance of the 
medial prefrontal cortex, subiculum, and amygdala, 
the consequences of stroke lesions in the LCSPT 
circuit, in terms of the prognosis and treatment of 
post-stroke depression, merit further investigation. 
  Our results also provide evidence that stroke 
lateralization is relevant for post-stroke depression. 
Despite some controversy (Singh et al. 1998; Carson 
et al. 2000; Bhogal et al. 2004; Yu et al. 2004; 
Hackett and Anderson 2005), major depression has 
been reported to be associated with left lesions in 
the ﬁ  rst months after stroke (Robinson et al. 1984a; 
Astrom et al. 1993; Herrmann et al. 1995; Beblo 
et al. 1999; Vataja et al. 2001, 2004). In our study, 
major depressive episode was associated with the 
volume of lesions in the LCSPT circuit of the left 
hemisphere but not with the volume of lesions in 
neural circuits in the right hemisphere. Other studies 
using MRI have also supported that left hemisphere 
location of stroke is relevant to the occurrence and 
severity of depression after three to four months 
after stroke (Vataja et al. 2001, 2004), and a study 
with PET found that the ratio of ipsilateral to con-
tralateral binding speciﬁ  c to S2 was correlated with 
severity of depressive symptoms one year after stroke 
in patients with left-hemisphere strokes but not those 
with right-hemisphere strokes (Mayberg et al. 1988). 
Of note, the relevance of left side location of stroke 
may not be generalized for all conditions of post-
stroke depression. For example, a literature review 
suggested that left side stroke lesions contribute to 
the development of post-stroke depression among 
inpatients, in contrast to community patients, where 
right side lesions were associated with post-stroke 
depression (Bhogal et al. 2004). Similarly, left side 
location was relevant for the development of depres-
sion during the acute but not chronic phase after 
stroke. In agreement with this review, we sampled 
inpatients and investigated the incidence of post-
stroke depression in a period of 4 months (mean 
91.6       5.4; 83  –  108 days) after stroke. 
  Certain limitations of our study should be consid-
ered. First, we excluded patients with hemorrhagic 
or infratentorial stroke, as well as those with a history 
of stroke or major depressive disorder. Consequently, 
it might not be possible to generalize our results to 
exhibits abnormal activity during periods of rest in 
depressive subjects (Soares and Mann 1997) and 
participates in the proposed default system, a net-
work that subserves the mental processes when the 
individual is not engaged in any speciﬁ  c  goal-
oriented task. The medial prefrontal cortex exerts 
modulation over visceral control structures in the 
hypothalamus and brainstem, which dysfunction can 
lead to disturbances in autonomic regulation, as well 
as to neuroendocrine responses associated with 
mood disorders (Drevets et al. 2008; Sheline et al. 
2009). The medial prefrontal cortex has been 
reported to be involved in the process of contextual 
association network (Bar et al. 2007). Lesions in the 
medial prefrontal cortex reduce the ability to disen-
gage the focus of attention from one task in order to 
move to another task. This phenomenon would 
explain the depressive rumination and inability of 
broadly association in patients with depression (Bar 
2009). The medial prefrontal cortex has also been 
shown to play a role in the response to treatment for 
depression. Hypermetabolism (Mayberg et al. 1997) 
and hyperactivity (Pizzagalli et al. 2001) in the ros-
tral anterior cingulate cortex and lower metabolism 
in the left ventral anterior cingulate (Brody et al. 
1999) have been associated with better antidepres-
sant response. In addition, changes in medial pre-
frontal cortex activity might be a condition for 
the amelioration of depression after treatment with 
antidepressants (Mayberg et al. 2000), with chronic 
high-frequency deep brain stimulation (Johansen-
Berg et al. 2008), or with cognitive behavioral ther-
apy (Goldapple et al. 2004). It is important to note 
that the ventral anterior cingulate cortex (BA24), the 
subgenual cortex (BA25), the dorsal anterior cingu-
late cortex (BA32), the amygdala (BA34), and 
the subiculum (BA28/BA36) are also part of the 
medial prefrontal network and the BA34 is also 
present in the orbital prefrontal network. Conse-
quently, although these networks did not present an 
association with post-stroke major depressive epi-
sode, lesions in the above mentioned structures may 
also be relevant for post-stroke major depressive epi-
sode by disrupting the medial prefrontal and the 
orbital prefrontal network. 
  The two other regions of the left LCSPT circuit 
in which lesion volume was associated with post-
stroke incidence of major depressive episode, the 
amygdala and the subiculum, have also been reported 
to play an important role in post-stroke depression 
and major depressive disorder. Lesions in the 
amygdala have previously been associated with post-
stroke depression (Vataja et al. 2001, 2004). In addi-
tion, studies of primary depression have indicated 
that amygdala hyperactivation (Peluso et al. 2009) 
is associated with depressive state, as well as that 546          L. Terroni et al.
subgenual cortex, amygdala and subiculum, were 
found to be associated with major depressive episode 
incidence within the 4-month period following a 
ﬁ   rst-ever ischemic stroke. Our ﬁ  ndings  suggest 
a neurobiological basis and a pathophysiological 
explanation for post-stroke depression. 
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